Olanzapine-induced tardive dystonia successfully treated by tetrabenazine.
Rauchverger
Boris
B
Isakov
Victoria
V
Jabarin
Mahmoud
M
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy; D013747:Tetrabenazine / Q000627:therapeutic use*
D018726:Anti-Dyskinesia Agents; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine; D013747:Tetrabenazine